+1 888-880-9539Search News by Tag: biotherapeutics
18 news stories found
Press Release
February 27, 2026
Creative Biotherapeutics, LLC, led by Anita Davidson, DPT, and Dr. Don Davidson, is advancing CBT300, an investigational biologic therapeutic candidate targeting drug resistance, immune evasion, recurrence, and metastasis in cancer treatment failure.
Read Press Release
Press Release
October 15, 2025
Anita Davidson is recognized for her contributions to the health care industry
Read Press Release
Press Release
August 8, 2025
Firelli Alonso, PhD, is recognized for their emerging contributions to the biotechnology industry
Read Press Release
Press Release
July 10, 2025
Stefan A. Fehr is a dynamic expert in training and development with over 30 years of experience in change management and continuous improvement
Read Press Release
Press Release
March 12, 2025
Creative Biolabs is leading the way in developing next-generation probiotics by assisting in the development of engineered strains with novel methods in gut microbiota research.
Read Press Release
Press Release
February 15, 2025
Creative Biolabs develops services for drug discovery using B. bifidum probiotics, which encompass strain design and genetic engineering.
Read Press Release
Press Release
January 14, 2025
Francis S. Kim is noted for his success as a medical director at Kyverna Therapeutics
Read Press Release
Press Release
December 13, 2024
In what is undoubtedly an impressive action, Creative Biolabs has made updates in its gut microbiota research technologies.
Read Press Release
Press Release
January 4, 2024
Igor D'Angelo is recognized for his expertise as the scientific director of Just–Evotec Biologics
Read Press Release
Press Release
December 7, 2023
Ms. Jamie M. Laury is lauded for her expertise as a senior scientist for upstream process development with FUJIFILM Diosynth Biotechnologies
Read Press Release
Press Release
December 2, 2021
Advisory and funding support is helping to advance this environmentally safe and sustainable yeast-based RNA production and oral delivery technology to precisely target specific genes in specific organisms, while avoiding damage to other organisms.
Read Press Release
Press Release
November 11, 2020
Dr. McChesney is a pharmaceutical scientist, entrepreneur and executive developing next-generation chemotherapy drugs
Read Press Release
Press Release
November 8, 2019
This year's conference will continue to focus and build on the challenges and hurdles that companies working in the microbiome industry will have to recognize and navigate in order to successfully commercialize their products.
Read Press Release
Press Release
June 19, 2018
Dr. McChesney is credited with conceiving and implementing the National Center for Natural Products Research
Read Press Release
Press Release
August 23, 2016
Arrowhead has published a new report entitled, "Microbiome Therapeutics and Diagnostics: Pipeline Analysis and Market".
Read Press Release
Press Release
August 21, 2015
Mr. Cox serves as COO of Jazz Pharmaceuticals, one of the nation's leading companies in the biopharmaceutical sector
Read Press Release
Press Release
July 1, 2013
It is that time of the year again for the 4th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems which will be organized by OMICS Group during March 24-26, 2014 in San Antonio, USA.
Read Press Release